Visar Belegu, Ph.D.
Affiliations: | 2004 | University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States |
Area:
Molecular Biology, BiochemistryGoogle:
"Visar Belegu"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Robert H. Broyles | grad student | 2004 | University of Oklahoma Health Sciences Center | |
| (A new function of heavy chain ferritin: Repressor of beta-globin.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Broyles RH, Joshi SK, Curtis CD, et al. (2014) Edx-17: A Novel, Safe and Efficacious Treatment for Sickle Cell Disease Blood. 124: 1357-1357 |
| Broyles R, Belegu V, Roth A, et al. (2010) A developmental switch yields a treatment for beta thalassemias and sickle cell disease Developmental Biology. 344: 525 |
| Broyles RH, Roth AC, Todd M, et al. (2006) Nuclear reprogramming by cell fusion. Methods in Molecular Biology (Clifton, N.J.). 325: 47-57 |
| Broyles RH, Belegu V, Roth AC, et al. (2006) Ferritin Heavy Chain Stimulates HbS-to-HbF Switching in Erythroid Precursor Cells from Sickle Cell Patients. Blood. 108: 790-790 |
| Broyles RH, Belegu V, Stewart CA, et al. (2004) Ferritin Heavy Chain, a Repressor of the Human β-Globin Gene That Binds a Conserved Cagtgc Motif, Is Bound to the Repressed β-Globin Promoter In Vivo in K562 Cells and Specifically Binds an Analogous Site in the Mouse β Major -Globin Promoter. Blood. 104: 1223-1223 |
| Broyles RH, Belegu V, DeWitt CR, et al. (2001) Specific repression of beta-globin promoter activity by nuclear ferritin. Proceedings of the National Academy of Sciences of the United States of America. 98: 9145-50 |